T2 Biosystems (NASDAQ:TTOO) has entered into an exclusive distribution agreement that allows the Company to introduce its rapid diagnostic technologies, including the T2Bacteria and T2Candida Panels, in Puerto Rico and the U.S. Virgin Islands, which have approx. 64 hospitals.
Shares are up 4% premarket.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.